Norton Children’s Neuroscience Institute, affiliated with the UofL School of Medicine, has created multidisciplinary clinics so children with spina bifida — and children with other complicated conditions — can see all subspecialists in one place during a single two- or three-hour visit. A child with spina bifida needs care from a number of specialists. As…
A powerful new technology gives neurosurgeons at Norton Children’s Neuroscience Institute, affiliated with the UofL School of Medicine, an incredible tool for planning complex surgeries and then sharing that information with patients and families in virtual reality (VR). The technology, called Surgical Theater, is capable of combining CT, MRI, fMRI and PET imaging into a…
Time saved is brain saved, and in recent years we’ve gotten some more time to save more brain. In 2018, the American Heart and American Stroke associations updated their guidelines to say perfusion scanning can make more patients with ischemic stroke and large vessel occlusion eligible for treatment up to 24 hours after symptoms first…
Norton Children’s Neuroscience Institute, affiliated with the UofL School of Medicine, brings pediatric neurosurgery, neurology, neuroradiology, pediatric rehabilitation and neuropsychology together in a collaborative role. “The goals are to provide excellent and convenient care for the patient and to bring different disciplines together,” said Vinay Puri, M.D., child neurologist-in-chief, Gretchen C. Rounsavall Medical Director in…
Norton Children’s has offered families multiple surgical interventions to address complex craniofacial pathology for more than 30 years. Paul Tessier, M.D., the father of craniofacial surgery, planted the seed by training surgeons who practiced in Louisville. Advanced surgical technology and a new streamlined experience for families at Norton Children’s Neuroscience Institute, affiliated with the UofL…
A baseline concussion test provides data to measure functional change in an athlete, making it crucial to concussion care, according to Tad D. Seifert, M.D., a neurologist and sports concussion specialist who is director of the Norton Neuroscience Institute Sports Neurology Center. In addition to offering information about the athlete’s behavior when healthy, baseline concussion…
Stroke in young people has been increasing, with adults as young as in their 20s at risk. This largely is due to more young people having risk factors previously associated with the older population: a sedentary lifestyle, obesity, high cholesterol, hypertension, diabetes and sleep apnea. Women on birth control who smoke and experience migraines with…
When a child presents with acute, sudden weakness, a neurologist needs to consider a broad spectrum of different diseases, according to Michael L. Sweeney, M.D., a pediatric neurologist with Norton Children’s Neuroscience Institute, affiliated with the UofL School of Medicine. “If someone is presenting with weakness that came on over the course of hours, it’s…
Interventional procedures may provide an option for patients with episodic migraine in cases where oral medications may be contraindicated because of comorbidities or because they don’t provide sufficient relief. Many of these treatments do not have adequate studies to support their use, particularly to the degree that regulatory bodies and insurers would permit. There are…
The choices parents have to face when considering elective brain surgery to treat refractory epilepsy can be overwhelming. Pediatric neurosurgeon Ian S. Mutchnick, M.D. M.S., and the refractory epilepsy team at Norton Children’s Neuroscience Institute, affiliated with the UofL School of Medicine, give patients and families clear, visually intuitive information about the patient’s epilepsy and…
In the past year, patients with relapsing forms of multiple sclerosis (MS) have gotten three new treatment options. Mavenclad (cladribine) is the most groundbreaking of the new drugs, in my opinion, due to its unique mechanism of action. Another drug, Mayzent (siponimod) became the first drug approved for active secondary progressive multiple sclerosis (SPMS). Active…
A new study published in Epilepsy Research found 64.3% of patients with various forms of drug-resistant epilepsy in the LAANTERN (Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System) registry were free of disabling seizures, reaching Engel I, after one year. Sixty patients were enrolled in the study specifically for epilepsy treatment. Forty-two reached…